Skip to main content
Back to Investors

Novo Holdings Portfolio Companies

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

Last updated: June 2026

Novo Holdings Investment Overview

Portfolio Companies
154
Total Invested
$9.7B
Average Investment
$85.4M

Novo Holdings's Most Recent Investments (2020+)

Company NameFoundedFunding StageAmountCity
Orbis Medicines2025Series A$93.2MFrederiksberg
Nuvig Therapeutics2024Series B$161.0MRedwood City
Convergent Therapeutics2024Series A$40.0MCambridge
Reduced2024Series A$8.9MCopenhagen
Kebotix2024Venture - Series Unknown$5.0MCambridge
Draupnir Bio2024Seed$13.2MRisskov
Myricx Bio2024Series A$115.3MLondon
CIRCTEC2024Venture - Series Unknown$162.8MLondon
Bluejay Therapeutics2024Series C$182.0MSan Mateo
Asgard Therapeutics2024Series A$32.6MLund

Complete List of Novo Holdings Portfolio Companies (154)

Export
#CompanyStageAmountLocation
26Orbis MedicinesSeries A$93.2MFrederiksberg, Denmark
27Nuvig TherapeuticsSeries B$161.0MRedwood City, United States
28Convergent TherapeuticsSeries A$40.0MCambridge, United States
29ReducedSeries A$8.9MCopenhagen, Denmark
30KebotixVenture - Series Unknown$5.0MCambridge, United States
31Draupnir BioSeed$13.2MRisskov, Denmark
32Myricx BioSeries A$115.3MLondon, United Kingdom
33CIRCTECVenture - Series Unknown$162.8MLondon, United Kingdom
34Bluejay TherapeuticsSeries C$182.0MSan Mateo, United States
35Asgard TherapeuticsSeries A$32.6MLund, Sweden
Health CareMedicalPharmaceuticalTherapeutics

Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.

Frederiksberg, Denmark
January 2025
$93.2M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

Redwood City, United States
December 2024
$161.0M
Series B

Founder Contacts

19,000+ verified contacts

Health CareMedicalPharmaceutical

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Cambridge, United States
September 2024
$40.0M
Series A

Founder Contacts

19,000+ verified contacts

Food and BeverageFood ProcessingOrganicSustainabilityWaste Management

Reduced develops natural flavor enhancers from upcycled produce.

Copenhagen, Denmark
September 2024
$8.9M
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)ChemicalIndustrialMachine Learning

Kebotix is a high-tech materials discovery and production company that reinvent the discovery of new materials using AI.

Cambridge, United States
August 2024
$5.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalTherapeutics

Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.

Risskov, Denmark
July 2024
$13.2M
Seed

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.

London, United Kingdom
July 2024
$115.3M
Series A

Founder Contacts

19,000+ verified contacts

ManufacturingRenewable EnergySustainability

CIRCTEC is an innovator and operator of pyrolysis technology to recycle waste into renewable fuels and circular chemicals.

London, United Kingdom
May 2024
$162.8M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

San Mateo, United States
May 2024
$182.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyTherapeutics

Asgard Therapeutics is a Biotechnology Company.

Lund, Sweden
March 2024
$32.6M
Series A

Founder Contacts

19,000+ verified contacts

Health CareMental HealthPersonal HealthWellness

Octave provides mental health care that's both accessible to people and sustainable for providers.

San Francisco, United States
February 2024
$5.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Health CareMedicalMedical Device

Nalu Medical is a medical technology company that develops innovative solutions for patients with chronic neuropathic pain.

Carlsbad, United States
January 2024
$85.0M
Series E

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.

Copenhagen, Denmark
December 2023
$24.8M
Series A

Founder Contacts

19,000+ verified contacts

Health CareHospitalInformation TechnologyTelehealthUnified Communications

Doctor Anywhere is a telehealth company .

Singapore, Singapore
December 2023
$40.8M
Series C

Founder Contacts

19,000+ verified contacts

MedicalPharmaceuticalTherapeutics

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

Risskov, Denmark
November 2023
$81.4M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalWellness

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Hellerup, Denmark
October 2023
$57.4M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Chemical

Pioneering the market introduction of powerful, autonomous, safe and eco-friendly water and air treatment solutions.

Copenhagen, Denmark
September 2023
$15.0M
Series A

Founder Contacts

19,000+ verified contacts

Health CareHealth InsuranceInsurance

Clever Care Health Plan is a healthcare company that offers medicare advantage health plans to its members.

Huntington Beach, United States
March 2023
$42.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyChemicalChemical Engineering

Chromologics develops innovative natural food colorants.

Søborg, Denmark
November 2025
$8.1M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalTherapeutics

Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.

Alderley Park, United Kingdom
February 2026
$8.1M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceutical

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

South San Francisco, United States
January 2026
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Biotechnology

Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.

Philadelphia, United States
January 2026
$197.0M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.

Copenhagen, Denmark
January 2026
$1.0M
Grant

Founder Contacts

19,000+ verified contacts

Alternative MedicineBiotechnologyHealth CareMedicalPrecision Medicine

Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.

Cambridge, United States
January 2026
$575.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Bactolife is a biotechnology company that develops biological solutions to support gut health.

Lyngby, Denmark
January 2026
$35.2M
Series B

Founder Contacts

19,000+ verified contacts

Showing 26-50 of 154 portfolio companies

Frequently Asked Questions About Novo Holdings

How many companies has Novo Holdings invested in?

Novo Holdings has invested in 154 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Novo Holdings invest in?

Novo Holdings's top investment sectors include Health Care, Biotechnology, Medical, Pharmaceutical, Therapeutics. The firm invests across 32 different industry categories.

What is Novo Holdings's largest investment?

Among tracked funding rounds, Praxis Precision Medicines received $575.0M in a Post Ipo Equity round. Novo Holdings's total known invested capital is $9.7B.

What is the average investment size for Novo Holdings?

Novo Holdings's average investment size is $85.4M across its portfolio of 154 companies.

What are Novo Holdings's most recent investments?

Recent Novo Holdings portfolio additions include Orbis Medicines, Nuvig Therapeutics, Convergent Therapeutics, Reduced, Kebotix. These companies were founded in 2020 or later.

Explore Other Top Investors

Discover portfolio companies of other leading venture capital firms and investors.

View All Investors